QRL-101
QRL-101 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS
A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants
A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants
A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants
Clinical Trials (5)
A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS
A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants
A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants
A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5